(1R,3S)-3-Amino-cyclopentanol
(Synonyms: (1R,3S)-3-氨基环戊醇) 目录号 : GC46317A synthetic intermediate useful for pharmaceutical synthesis
Cas No.:1110772-05-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
(1R,3S)-3-Amino-cyclopentanol is a synthetic intermediate useful for pharmaceutical synthesis.
N/A
| Cas No. | 1110772-05-8 | SDF | |
| 别名 | (1R,3S)-3-氨基环戊醇 | ||
| Canonical SMILES | N[C@H]1CC[C@@H](O)C1 | ||
| 分子式 | C5H11NO | 分子量 | 101.1 |
| 溶解度 | Ethanol: soluble | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 9.8912 mL | 49.456 mL | 98.912 mL |
| 5 mM | 1.9782 mL | 9.8912 mL | 19.7824 mL |
| 10 mM | 0.9891 mL | 4.9456 mL | 9.8912 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
[(1R,3S)-3-(1,3-Dithian-2-yl)-2,2-dimethyl-cyclo-prop-yl]diphenyl-methanol
Acta Crystallogr Sect E Struct Rep Online 2009 May 7;65(Pt 6):o1230.PMID:21583098DOI:10.1107/S1600536809016079.
In the title compound, C(22)H(26)OS(2), prepared from (-)-1R-cis-caronaldehyde, the 1,3-dithiane ring adopts a chair conformation. An intra-molecular O-H⋯S hydrogen bond influences the mol-ecular conformation. In the crystal, weak inter-molecular C-H⋯S and C-H⋯O hydrogen bonds link the mol-ecules into chains propagating along [010].
(1R,3S,4R,4aS,7R,7aS,10R,12aR)-3-Azido-4,7,10-trimethyl-1,10-epidioxy-per-hydropyrano[4,3-j][1,2]benzodiox-epine
Acta Crystallogr Sect E Struct Rep Online 2010 Jun 26;66(Pt 7):o1839.PMID:21588040DOI:10.1107/S1600536810024566.
In the title compound, C(15)H(23)N(3)O(4), the six-membered pyran, cyclo-hexane and trioxane rings adopt chair, chair and boat conformations, respectively, while the seven-membered rings adopt distorted boat and very distorted chair conformations. In the crystal, adjacent mol-ecules are connected by weak C-H⋯N and C-H⋯O inter-actions.
(1R,3S,8R)-3,7,7,10-Tetra-methyl-tri-cyclo-[6.4.0.0(1,3)]dodec-9-en-11-one
Acta Crystallogr Sect E Struct Rep Online 2013 Dec 21;70(Pt 1):o81-2.PMID:24527013DOI:10.1107/S1600536813034041.
The absolute configuration of the title compound, C16H24O, has been deduced from the chemical pathway. The six-membered ring has a roughly half-chair conformation with the quaternary C atom as the flap. The seven-membered ring displays a chair conformation. In the crystal, there is a weak C-H⋯O hydrogen bond between the methyl-ene group of the cyclo-propane ring and the carbonyl group of a screw-axis-related mol-ecule, which builds up a zigzag-like chain along the b-axis direction.
(1R,3S)-3-Hydroxy-meth-yl-N-isopropyl-2,2-dimethyl-cyclo-propane-carboxamide
Acta Crystallogr Sect E Struct Rep Online 2009 Dec 12;66(Pt 1):o118.PMID:21580007DOI:10.1107/S1600536809051538.
The asymmetric unit of the title compound, C(10)H(19)NO(2), prepared from (-)-1R-cis-caronaldehyde, contains two independent mol-ecules. In the crystal structure, inter-molecular O-H⋯O and O-H⋯N hydrogen bonds form an extensive three-dimensional hydrogen-bonding network.
[(1R,3S)-6,7-Dimeth-oxy-1-phenyl-1,2,3,4-tetra-hydro-isoquinolin-3-yl]methanol 2.33-hydrate
Acta Crystallogr Sect E Struct Rep Online 2011 Feb 23;67(Pt 3):o700.PMID:21522445DOI:10.1107/S1600536811006052.
The title compound, C(18)H(21)NO(3)·2.33H(2)O, is the fourth reported member in a series of (1R,3S)-6,7-dimeth-oxy-1-phenyl-1,2,3,4-tetra-hydro-isoquinoline derivatives used in catalysis as ligands (or their precursors). The N-heterocycle in the structure adopts a half-chair conformation. The dihedral angle between the benzene rings is 77.29 (13)°. There are three ill-resolved water molecules of crystallization in the structure (one of them rotationally disordered about a threefold axis) involved in short contacts probably due to hydrogen bonding.